Clinical Trial: A Study on the Diagnostic Value of Contrast-Enhanced Ultrasound Quantitative Analysis Adjusted O-RADS Classification Combined with Tumor Markers in Differentiating Benign and Malignant Ovarian-Adnexal Masses (China)

China, Sept. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Diagnostic Value of Contrast-Enhanced Ultrasound Quantitative Analysis Adjusted O-RADS Classification Combined with Tumor Markers in Differentiating Benign and Malignant Ovarian-Adnexal Masses'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131422

Registration Time: 2026/09/02

Type: Diagnostic test

Primary Sponsor: Wuxi Second People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=306013

Published by HT Digital Content Services with permission from Health Daily Digest....